GSA Capital Partners LLP Buys 5,056 Shares of Cigna Group $CI

GSA Capital Partners LLP grew its stake in Cigna Group (NYSE:CI) by 311.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,680 shares of the health services provider’s stock after buying an additional 5,056 shares during the period. GSA Capital Partners LLP’s holdings in Cigna Group were worth $1,842,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Wilkerson Advisory Group LLC acquired a new stake in Cigna Group during the 4th quarter valued at approximately $25,000. Kemnay Advisory Services Inc. acquired a new position in shares of Cigna Group in the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc bought a new stake in shares of Cigna Group in the 4th quarter valued at $29,000. Cedar Mountain Advisors LLC boosted its stake in shares of Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 68 shares during the last quarter. Finally, ANTIPODES PARTNERS Ltd acquired a new stake in shares of Cigna Group during the second quarter worth $34,000. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

NYSE:CI opened at $282.24 on Monday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The company has a fifty day moving average of $286.02 and a 200-day moving average of $281.28. The firm has a market capitalization of $74.58 billion, a P/E ratio of 11.68, a P/E/G ratio of 0.97 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group’s revenue was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction that occurred on Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the transaction, the insider directly owned 27,256 shares in the company, valued at approximately $7,530,015.12. This trade represents a 41.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company lifted their target price on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research note on Friday, July 31st. Mizuho upped their price target on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Morgan Stanley increased their price target on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a report on Wednesday, May 20th. Sanford C. Bernstein lifted their price objective on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Finally, Robert W. Baird set a $362.00 price objective on Cigna Group in a research note on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.